Screening for Epidermal Growth Factor Receptor Mutations in Lung CancerRafael Rosell, Miquel Tarón, Dolores Isla et al.|New England Journal of Medicine|2009Cited by 2.4k
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patientsH. Cortés-Funes, Miquel Tarón, Carlos Gegúndez Gómez et al.|Annals of Oncology|2005Cited by 231
Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the UrotheliumJoaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares et al.|Journal of Clinical Oncology|2000Cited by 191
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of ActionIgnacio Durán, Oriol Casanovas, J. Lambea et al.|Targeted Oncology|2016Cited by 103